248 related articles for article (PubMed ID: 30350524)
1. Increasing challenges of inflammatory bowel disease in a Turkish cohort (2006-2016).
Yuksel I; Kilincalp S; Coşkun Y; Akinci H; Karaahmet F; Hamamci M
Acta Gastroenterol Belg; 2018; 81(3):373-380. PubMed ID: 30350524
[TBL] [Abstract][Full Text] [Related]
2. Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy.
Gasparetto M; Guariso G; Pozza LV; Ross A; Heuschkel R; Zilbauer M
BMC Gastroenterol; 2016 Mar; 16():35. PubMed ID: 26976427
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
4. Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.
Jeuring SF; van den Heuvel TR; Liu LY; Zeegers MP; Hameeteman WH; Romberg-Camps MJ; Oostenbrug LE; Masclee AA; Jonkers DM; Pierik MJ
Am J Gastroenterol; 2017 Feb; 112(2):325-336. PubMed ID: 27922024
[TBL] [Abstract][Full Text] [Related]
5. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
[TBL] [Abstract][Full Text] [Related]
7. Advances in Pediatric Inflammatory Bowel Disease.
Maxwell EC; Grossman AB
Adolesc Med State Art Rev; 2016; 27(1):57-74. PubMed ID: 27363233
[No Abstract] [Full Text] [Related]
8. Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications.
Targownik LE; Benchimol EI; Bernstein CN; Singh H; Tennakoon A; Zubieta AA; Coward S; Jones J; Kaplan GG; Kuenzig ME; Murthy SK; Nguyen GC; Peña-Sánchez JN
J Crohns Colitis; 2020 Oct; 14(10):1354-1363. PubMed ID: 32648579
[TBL] [Abstract][Full Text] [Related]
9. Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery.
Barnes EL; Goldin A; Winter RW; Collins E; Cao B; Carrellas M; Crowell AM; Korzenik JR
Dig Dis Sci; 2016 Nov; 61(11):3261-3269. PubMed ID: 27639871
[TBL] [Abstract][Full Text] [Related]
10. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
11. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
[TBL] [Abstract][Full Text] [Related]
12. Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
Targownik LE; Benchimol EI; Bernstein CN; Singh H; Lix L; Tennakoon A; Leung S; Aviña A; Coward S; Jones J; Kaplan G; Murthy SK; Nguyen GC; Peña-Sánchez JN
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1788-1798.e2. PubMed ID: 30448599
[TBL] [Abstract][Full Text] [Related]
13. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011.
Rungoe C; Langholz E; Andersson M; Basit S; Nielsen NM; Wohlfahrt J; Jess T
Gut; 2014 Oct; 63(10):1607-16. PubMed ID: 24056767
[TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in Switzerland.
Schoepfer A; Vavricka SR; Brüngger B; Reich O; Blozik E; Bähler C
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):868-875. PubMed ID: 29757772
[TBL] [Abstract][Full Text] [Related]
15. Increasing rate of inflammatory bowel disease: a 12-year retrospective study in NingXia, China.
Zhai H; Liu A; Huang W; Liu X; Feng S; Wu J; Yao Y; Wang C; Li Q; Hao Q; Hu J; Zhang S
BMC Gastroenterol; 2016 Jan; 16():2. PubMed ID: 26754840
[TBL] [Abstract][Full Text] [Related]
16. Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN.
Aloi M; Birimberg-Schwartz L; Buderus S; Hojsak I; Fell JM; Bronsky J; Veereman G; Koletzko S; Shaoul R; Miele E; Turner D; Russell RK
Inflamm Bowel Dis; 2016 Jun; 22(6):1378-83. PubMed ID: 27135479
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolism as an important complication of inflammatory bowel disease.
Bollen L; Vande Casteele N; Ballet V; van Assche G; Ferrante M; Vermeire S; Gils A
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):1-7. PubMed ID: 26513610
[TBL] [Abstract][Full Text] [Related]
18. Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs.
Bossa F; Carparelli S; Latiano A; Palmieri O; Tavano F; Panza A; Pastore M; Marseglia A; D'Altilia M; Latiano T; Corritore G; Martino G; Nardella M; Guerra M; Terracciano F; Sacco M; Perri F; Andriulli A
Dig Liver Dis; 2021 Mar; 53(3):277-282. PubMed ID: 33423942
[TBL] [Abstract][Full Text] [Related]
19. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
[TBL] [Abstract][Full Text] [Related]
20. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.
Müller KE; Lakatos PL; Arató A; Kovács JB; Várkonyi Á; Szűcs D; Szakos E; Sólyom E; Kovács M; Polgár M; Nemes É; Guthy I; Tokodi I; Tóth G; Horváth Á; Tárnok A; Csoszánszki N; Balogh M; Vass N; Bódi P; Dezsőfi A; Gárdos L; Micskey E; Papp M; Cseh Á; Szabó D; Vörös P; Veres G;
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
